Keros Therapeutics, Inc. (KROS)
16.56
-0.05
(-0.30%)
USD |
NASDAQ |
Feb 13, 16:00
16.56
0.00 (0.00%)
After-Hours: 16:07
Keros Therapeutics Free Cash Flow : 87.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| MannKind Corp. | 42.74M |
| Sarepta Therapeutics, Inc. | -401.63M |
| Insmed, Inc. | -906.14M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.249M |
| Cash from Investing (Quarterly) | -0.132M |
| Cash from Financing (Quarterly) | 0.14M |
| Free Cash Flow Per Share (Quarterly) | 0.0767 |
| Free Cash Flow to Equity (Quarterly) | 3.642M |
| Free Cash Flow to Firm (Quarterly) | 3.117M |
| Free Cash Flow Yield | 12.94% |